Skip to main content
Fig. 5 | Systematic Reviews

Fig. 5

From: Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: a systematic review and meta-analysis

Fig. 5

Pooled pCR outcome of TA-treated Asian breast cancer patients according to biomarkers. Forest plots describing the random effect ORs and 95% CIs from studies assessing the association of pCR outcome in NAC TA-treated breast cancer patients in biomarkers (A) PR; (B) HR; (C) HER2; (D) nm23-H1; and (E) CK5/6. I2 and p-value for X2 of heterogeneity are reported for each group analysis

Back to article page

Systematic Reviews

ISSN: 2046-4053